Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

TRAC Tool

by Ogilvy Health for Bayer. ... Optimising Comprehension of a Complex Pharmacokinetic Dataset in Haemophilia: A Through Cognitive Psychology and Information Design - by Ogilvy Health for Bayer.

Big Data for in Silico R&D: Visualizing label expansion opportunities

by Ogilvy Health for Bayer. ... Optimising Comprehension of a Complex Pharmacokinetic Dataset in Haemophilia: A Through Cognitive Psychology and Information Design - by Ogilvy Health for Bayer.

The Heart Failure Data Map: Visualising A Growing Health Priority

by Ogilvy Health for Bayer. ... Optimising Comprehension of a Complex Pharmacokinetic Dataset in Haemophilia: A Through Cognitive Psychology and Information Design - by Ogilvy Health for Bayer.

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m. ... BlueRock – a Bayer subsidiary – is currently evaluating the pluripotent stem cell-derived dopaminergic neuron therapy in a

Fool’s gold or pot of gold? The challenges of demonstrating the value of tumour agnostic therapies

Fool’s gold or pot of gold? The challenges of demonstrating the value of tumour agnostic therapies Current forecasts suggest that by 2026 sales will reach $596m for Vitrakvi and $402m for Rozlytrek, accounting for 2.7% of Bayer’s sales and 1% of Roche’s respectively.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Visformatics (VISFO)

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...